Request for Covid-19 Impact Assessment of this Report
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and nasal spray.The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The nasal spray is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis.
The global Budesonide market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Nasal spray
Inhaler
Pill&Rectal forms
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
AstraZeneca
Cosmo Pharmaceuticals
Teva
Mylan
Sandoz
Dr. Falk Pharma
Chiesi Farmaceutici S.p.A
Orion Corporation
Cipla
Synmosa Biopharma Corporation
Lunan Better Pharmaceutical
Shanghai Sine Promod Pharmaceutical
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Respiratory disease treatment
Nose disease treatment
Inflammatory bowel disease treatment
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
Figure Budesonide Picture
1.1.2 Specifications
Table Product Specifications of Budesonide
1.2 Market Segment
1.2.1 by Type
Table Products Segment of Budesonide
Table Global Budesonide Market by Type, 2011-2022 (USD Million)
1.2.1.1 Nasal spray
Table Nasal spray Overview
1.2.1.2 Inhaler
Table Inhaler Overview
1.2.1.3 Pill&Rectal forms
Table Pill&Rectal forms Overview
1.2.2 by Application
Table Application Segment of Budesonide
Table Global Budesonide Market by Application, 2011-2022 (USD Million)
1.2.2.1 Respiratory disease treatment
Table Respiratory disease treatment Overview
1.2.2.2 Nose disease treatment
Table Nose disease treatment Overview
1.2.2.3 Inflammatory bowel disease treatment
Table Inflammatory bowel disease treatment Overview
1.2.3 by Regions
Table Global Budesonide Market by Region, 2011-2022 (USD Million)
2 Industry Chain
2.1 Industry Chain Structure
Figure Industry Chain Structure of Budesonide
2.2 Upstream
Table Cost of Budesonide
Figure Manufacturing Process of Budesonide
2.3 Market
2.3.1 SWOT
Figure SWOT of Budesonide
2.3.2 Dynamics
Table Market Dynamics
3 Environmental Analysis
3.1 Policy
Table Policy of Budesonide
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of Budesonide
3.4 Market Entry
Table Market Entry of Budesonide
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Nasal spray Market, 2013-2018
Figure Nasal spray Market Size and Growth, 2012-2018 (USD Million)
Figure Nasal spray Market Size and Growth, 2012-2018 (in Volume)
Table Nasal spray CAGR by Revenue and Volume, 2012-2018
4.1.2 Inhaler Market, 2013-2018
Figure Inhaler Market Size and Growth, 2012-2018 (USD Million)
Figure Inhaler Market Size and Growth, 2012-2018 (in Volume)
Table Inhaler CAGR by Revenue and Volume, 2012-2018
4.1.3 Pill&Rectal forms Market, 2013-2018
Figure Pill&Rectal forms Market Size and Growth, 2012-2018 (USD Million)
Figure Pill&Rectal forms Market Size and Growth, 2012-2018 (in Volume)
Table Pill&Rectal forms CAGR by Revenue and Volume, 2012-2018
4.2 Market Forecast
4.2.1 Nasal spray Market Forecast, 2020-2025
Figure Nasal spray Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Nasal spray Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Nasal spray CAGR by Revenue and Volume, 2012-2024
4.2.2 Inhaler Market Forecast, 2020-2025
Figure Inhaler Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Inhaler Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Inhaler CAGR by Revenue and Volume, 2012-2024
4.2.3 Pill&Rectal forms Market Forecast, 2020-2025
Figure Pill&Rectal forms Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Pill&Rectal forms Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Pill&Rectal forms CAGR by Revenue and Volume, 2012-2024
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Respiratory disease treatment Market, 2013-2018
Figure Respiratory disease treatment Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Table Respiratory disease treatment CAGR by Revenue and Volume, 2012-2018
5.1.2 Nose disease treatment Market, 2013-2018
Figure Nose disease treatment Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Table Nose disease treatment CAGR by Revenue and Volume, 2012-2018
5.1.3 Inflammatory bowel disease treatment Market, 2013-2018
Figure Inflammatory bowel disease treatment Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Table Inflammatory bowel disease treatment CAGR by Revenue and Volume, 2012-2018
5.2 Market Forecast
5.2.1 Respiratory disease treatment Market Forecast, 2020-2025
Figure Respiratory disease treatment Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Respiratory disease treatment Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Respiratory disease treatment CAGR by Revenue and Volume, 2020-2025
5.2.2 Nose disease treatment Market Forecast, 2020-2025
Figure Nose disease treatment Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Nose disease treatment Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Nose disease treatment CAGR by Revenue and Volume, 2020-2025
5.2.3 Inflammatory bowel disease treatment Market Forecast, 2020-2025
Figure Inflammatory bowel disease treatment Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Inflammatory bowel disease treatment Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Inflammatory bowel disease treatment CAGR by Revenue and Volume, 2020-2025
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2012-2018
Figure Asia-Pacific Market Size and Growth, 2012-2018 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2012-2018
6.1.1.2 Asia-Pacific Market by Type
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
6.1.1.3 Asia-Pacific Market by Application
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
6.1.2 North America
6.1.2.1 North America Market, 2012-2018
Figure North America Market Size and Growth, 2012-2018 (USD Million)
Figure North America Market Size and Growth, 2012-2018 (in Volume)
Table North America CAGR by Revenue and Volume, 2012-2018
6.1.2.2 North America Market by Type
Figure North America Market Size by Type
Figure North America Market Share by Type
6.1.2.3 North America Market by Application
Figure North America Market Size by Application
Figure North America Market Share by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2012-2018
Figure Europe Market Size and Growth, 2012-2018 (USD Million)
Figure Europe Market Size and Growth, 2012-2018 (in Volume)
Table Europe CAGR by Revenue and Volume, 2012-2018
6.1.3.2 Europe Market by Type
Figure Europe Market Size by Type
Figure Europe Market Share by Type
6.1.3.3 Europe Market by Application
Figure Europe Market Size by Application
Figure Europe Market Share by Application
6.1.4 South America
6.1.4.1 South America Market, 2012-2018
Figure South America Market Size and Growth, 2012-2018 (USD Million)
Figure South America Market Size and Growth, 2012-2018 (in Volume)
Table South America CAGR by Revenue and Volume, 2012-2018
6.1.4.2 South America Market by Type
Figure South America Market Size by Type
Figure South America Market Share by Type
6.1.4.3 South America Market by Application
Figure South America Market Size by Application
Figure South America Market Share by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2012-2018
Figure Middle East & Africa Market Size and Growth, 2012-2018 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2012-2018 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2012-2018
6.1.5.2 Middle East & Africa Market by Type
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
6.1.5.3 Middle East & Africa Market by Application
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2020-2025
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
6.2.2 North America Market Forecast, 2020-2025
Figure North America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure North America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table North America CAGR by Revenue and Volume, 2020-2025
6.2.3 Europe Market Forecast, 2020-2025
Figure Europe Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Europe Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Europe CAGR by Revenue and Volume, 2020-2025
6.2.4 South America Market Forecast, 2020-2025
Figure South America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure South America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table South America CAGR by Revenue and Volume, 2020-2025
6.2.5 Middle East & Africa Market Forecast, 2020-2025
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
7 Market Competitive
7.1 Global Market by Vendors
Table Global Budesonide Market by Vendors, 2012-2018 (in Volume)
Table Global Budesonide Market Share by Vendors, 2012-2018 (USD Million)
Table Global Budesonide Market Share by Vendors, 2012-2018 (in Volume)
7.2 Market Concentration
Figure Budesonide Market Concentration by Region
7.3 Price & Factors
Table Price Factors List
7.4 Marketing Channel
Figure Marketing Channels Overview
8 Major Vendors
8.1 AstraZeneca
Table AstraZeneca Profile List
Table Microecological Modulator Operating Data of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.2 Cosmo Pharmaceuticals
Table Cosmo Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Cosmo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.3 Teva
Table Teva Profile List
Table Microecological Modulator Operating Data of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.4 Mylan
Table Mylan Profile List
Table Microecological Modulator Operating Data of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.5 Sandoz
Table Sandoz Profile List
Table Microecological Modulator Operating Data of Sandoz (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.6 Dr. Falk Pharma
Table Dr. Falk Pharma Profile List
Table Microecological Modulator Operating Data of Dr. Falk Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.7 Chiesi Farmaceutici S.p.A
Table Chiesi Farmaceutici S.p.A Profile List
Table Microecological Modulator Operating Data of Chiesi Farmaceutici S.p.A (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.8 Orion Corporation
Table Orion Corporation Profile List
Table Microecological Modulator Operating Data of Orion Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.9 Cipla
Table Cipla Profile List
Table Microecological Modulator Operating Data of Cipla (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.10 Synmosa Biopharma Corporation
Table Synmosa Biopharma Corporation Profile List
Table Microecological Modulator Operating Data of Synmosa Biopharma Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.11 Lunan Better Pharmaceutical
Table Lunan Better Pharmaceutical Profile List
Table Microecological Modulator Operating Data of Lunan Better Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.12 Shanghai Sine Promod Pharmaceutical
Table Shanghai Sine Promod Pharmaceutical Profile List
Table Microecological Modulator Operating Data of Shanghai Sine Promod Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9 Conclusion
Table Product Specifications of Budesonide
Table Products Segment of Budesonide
Table Global Budesonide Market by Type, 2011-2022 (USD Million)
Table Nasal spray Overview
Table Inhaler Overview
Table Pill&Rectal forms Overview
Table Application Segment of Budesonide
Table Global Budesonide Market by Application, 2011-2022 (USD Million)
Table Respiratory disease treatment Overview
Table Nose disease treatment Overview
Table Inflammatory bowel disease treatment Overview
Table Global Budesonide Market by Region, 2011-2022 (USD Million)
Table Cost of Budesonide
Table Market Dynamics
Table Policy of Budesonide
Table GDP of Major Countries
Table Technology of Budesonide
Table Market Entry of Budesonide
Table Nasal spray CAGR by Revenue and Volume, 2012-2018
Table Inhaler CAGR by Revenue and Volume, 2012-2018
Table Pill&Rectal forms CAGR by Revenue and Volume, 2012-2018
Table Nasal spray CAGR by Revenue and Volume, 2012-2024
Table Inhaler CAGR by Revenue and Volume, 2012-2024
Table Pill&Rectal forms CAGR by Revenue and Volume, 2012-2024
Table Respiratory disease treatment CAGR by Revenue and Volume, 2012-2018
Table Nose disease treatment CAGR by Revenue and Volume, 2012-2018
Table Inflammatory bowel disease treatment CAGR by Revenue and Volume, 2012-2018
Table Respiratory disease treatment CAGR by Revenue and Volume, 2020-2025
Table Nose disease treatment CAGR by Revenue and Volume, 2020-2025
Table Inflammatory bowel disease treatment CAGR by Revenue and Volume, 2020-2025
Table Asia-Pacific CAGR by Revenue and Volume, 2012-2018
Table North America CAGR by Revenue and Volume, 2012-2018
Table Europe CAGR by Revenue and Volume, 2012-2018
Table South America CAGR by Revenue and Volume, 2012-2018
Table Middle East & Africa CAGR by Revenue and Volume, 2012-2018
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
Table North America CAGR by Revenue and Volume, 2020-2025
Table Europe CAGR by Revenue and Volume, 2020-2025
Table South America CAGR by Revenue and Volume, 2020-2025
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
Table Global Budesonide Market by Vendors, 2012-2018 (in Volume)
Table Global Budesonide Market Share by Vendors, 2012-2018 (USD Million)
Table Global Budesonide Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table AstraZeneca Profile List
Table Microecological Modulator Operating Data of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cosmo Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Cosmo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Profile List
Table Microecological Modulator Operating Data of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mylan Profile List
Table Microecological Modulator Operating Data of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sandoz Profile List
Table Microecological Modulator Operating Data of Sandoz (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dr. Falk Pharma Profile List
Table Microecological Modulator Operating Data of Dr. Falk Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Chiesi Farmaceutici S.p.A Profile List
Table Microecological Modulator Operating Data of Chiesi Farmaceutici S.p.A (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Orion Corporation Profile List
Table Microecological Modulator Operating Data of Orion Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cipla Profile List
Table Microecological Modulator Operating Data of Cipla (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Synmosa Biopharma Corporation Profile List
Table Microecological Modulator Operating Data of Synmosa Biopharma Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Lunan Better Pharmaceutical Profile List
Table Microecological Modulator Operating Data of Lunan Better Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Shanghai Sine Promod Pharmaceutical Profile List
Table Microecological Modulator Operating Data of Shanghai Sine Promod Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...